glp 1 agonist vs sglt2 inhibitor Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application SGLT-2 inhibitors and GLP-1 receptor
Description
Without deliberate structure around protein , hydration , movement , and timing , the same drug that produces dramatic results can trigger muscle loss , fatigue , or side effects that halt progress

We can also all integrate more forms of eating disorder prevention in our daily lives, including: changing the way we talk about others appearances, shifting our language around food and dieting, and educating ourselves on fatphobia and fat stigma

However, combining medications should only be done under medical supervision

doi: 10.1016/S2213-8587(18)30104-9

outlined several systemic advantages of GLP-1 RAs, including weight loss, glycemic control, cardiovascular protection (e.g., reduced incidence of myocardial infarction and stroke), and their role as a non-surgical alternative to bariatric procedures
